Bridgeway Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,175
| Closed | -$74K | – | 1409 |
|
|
2022
Q1 | $74K | Hold |
9,175
| – | – | ﹤0.01% | 1278 |
|
|
2021
Q4 | $122K | Sell |
9,175
-7,500
| -45% | -$99.7K | ﹤0.01% | 1205 |
|
|
2021
Q3 | $727K | Buy |
16,675
+1,675
| +11% | +$73K | 0.01% | 924 |
|
|
2021
Q2 | $627K | Buy |
+15,000
| New | +$627K | 0.01% | 1005 |
|
|
2020
Q1 | – | Sell |
-10,100
| Closed | -$1.15M | – | 1384 |
|
|
2019
Q4 | $1.15M | Hold |
10,100
| – | – | 0.02% | 708 |
|
|
2019
Q3 | $624K | Buy |
10,100
+2,500
| +33% | +$154K | 0.01% | 863 |
|
|
2019
Q2 | $593K | Buy |
7,600
+1,250
| +20% | +$97.5K | 0.01% | 923 |
|
|
2019
Q1 | $856K | Buy |
6,350
+500
| +9% | +$67.4K | 0.01% | 816 |
|
|
2018
Q4 | $469K | Buy |
5,850
+2,500
| +75% | +$200K | 0.01% | 1018 |
|
|
2018
Q3 | $352K | Sell |
3,350
-3,720
| -53% | -$391K | ﹤0.01% | 1219 |
|
|
2018
Q2 | $707K | Hold |
7,070
| – | – | 0.01% | 1014 |
|
|
2018
Q1 | $891K | Buy |
7,070
+4,690
| +197% | +$591K | 0.01% | 892 |
|
|
2017
Q4 | $397K | Sell |
2,380
-1,023
| -30% | -$171K | ﹤0.01% | 1157 |
|
|
2017
Q3 | $1.07M | Sell |
3,403
-2,977
| -47% | -$938K | 0.01% | 826 |
|
|
2017
Q2 | $1.9M | Hold |
6,380
| – | – | 0.02% | 602 |
|
|
2017
Q1 | $1.47M | Sell |
6,380
-1,525
| -19% | -$352K | 0.02% | 672 |
|
|
2016
Q4 | $514K | Buy |
7,905
+12
| +0.2% | +$780 | 0.01% | 1081 |
|
|
2016
Q3 | $513K | Hold |
7,893
| – | – | 0.01% | 1094 |
|
|
2016
Q2 | $586K | Buy |
7,893
+4,000
| +103% | +$297K | 0.01% | 975 |
|
|
2016
Q1 | $442K | Hold |
3,893
| – | – | 0.01% | 1105 |
|
|
2015
Q4 | $596K | Buy |
3,893
+2,368
| +155% | +$363K | 0.01% | 986 |
|
|
2015
Q3 | $166K | Buy |
+1,525
| New | +$166K | ﹤0.01% | 1336 |
|